From genomic variants,to clear clinical decisions.In under 5 minutes.
Clinician-ready interpretation in under 5 minutes.GeneGenius turns raw genomic output into clinician-ready interpretation with a median turnaround under 5 minutes.
Why this matters right now
Interpretation is the bottleneck. Specialist capacity limits answers; the U.S. rare disease burden nears $1T annually.Clinical demand is scaling faster than specialist capacity. Sequencing is no longer the bottleneck. Interpretation throughput and expert bandwidth now define how fast patients get answers. The U.S. rare disease burden alone is nearing $1T annually.
End-to-End GPU Genomics Intelligence
GPU-accelerated analysis and managed inference for clinical teams.Operational backbone for programs at scale: GPU-accelerated primary analysis, managed model inference, and reproducible pipelines, with the observability and controls teams expect when workloads run continuously, not as one-off jobs.
GPU-Accelerated Variant Calling
GPU-accelerated alignment and variant calling for full genomes in minutes.Full 30× whole-genome sequencing processed through GPU-accelerated alignment and variant calling — reducing turnaround from ~30 hours on CPU to minutes.
Scalable AI Inference
Clinical NLP and pathogenicity inference at scale with autoscaling.Clinical NLP and pathogenicity workloads run on BioNeMo-backed infrastructure with production-grade batching and autoscaling.
Integrated Drug Intelligence
Interpretations linked to PharmGKB, OpenFDA, and clinical evidence.Interpretations are grounded in PharmGKB and OpenFDA label data alongside clinical and population evidence to connect variants to therapeutic relevance.
Clinical-Grade Adoption
200+ researchers use GeneGenius daily in active programs.More than 200 researchers use GeneGenius daily to review, validate, and operationalize genomic interpretation in active programs.
Non-Coding Variant Classification
Non-coding classification with explainable evidence links.GeneGenius classifies non-coding variants with explainable evidence links. Pedigree and family analysis workflows are in development.
Who is this for?
Built for teams that need faster, reliable interpretation.GeneGenius is designed for teams who need faster, more reliable genomic interpretation.
Clinical Genomics Labs
CLIA-certified labs seeking faster, consistent interpretation.CLIA-certified and research laboratories seeking faster, more consistent variant interpretation workflows.
Hospital Genomics Programs
Health systems scaling genomics with lean bioinformatics teams.Health systems building or scaling clinical genomics services with limited bioinformatics staff.
Oncology Diagnostics Teams
Tumor boards and oncology teams interpreting variants.Molecular tumor boards and precision oncology teams interpreting somatic and germline variants.
Rare Disease Research Groups
Researchers analyzing exomes and genomes for rare disease.Academic and clinical researchers analyzing whole-exome and whole-genome sequencing for rare disease diagnosis.
Where genomic interpretation
drives decisions
Structured interpretation that drives clinical decisions.From rare disease diagnostics to precision oncology, structured AI‑driven interpretation supports confident clinical action.
Diagnostic Clarity
Faster rare disease interpretation with evidence-backed clarity.Accelerate the interpretation of variants in rare disease cases. Reduce uncertainty by synthesizing evidence from literature, functional studies, and clinical databases to support diagnostic decisions.
Therapy Relevance
Connect tumor variants to actionable therapies and trials.Identify actionable variants linked to targeted therapies, clinical trials, and treatment guidelines. Connect tumor genomics to evidence based therapeutic options.
Treatment Response
Pharmacogenomic insights for medication selection and dosing.Interpret pharmacogenomic variants that affect drug metabolism and efficacy. Align findings with CPIC guidelines to support medication selection and dosing decisions.
PharmGKB